MARC details
000 -LEADER |
fixed length control field |
01990nam a2200265Ia 4500 |
000 - LEADER |
fixed length control field |
02226naaa 00289uu |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/40128 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20211222133721.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
211013s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781838802042 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.5772/intechopen.73455 |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gyula Mozsik |
245 #0 - TITLE STATEMENT |
Title |
Adenosine Triphosphate in Health and Disease |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Name of publisher, distributor, etc. |
IntechOpen |
Date of publication, distribution, etc. |
2019 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (84 p.) |
506 ## - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book covers a very important research field; specifically, it tries to decrease the gap between theoretical and clinical research. The tendency of world research is to gain a detailed insight into the living organs of animals and humans. However, we must not lose sight of the problems that these organs can present; for example, we need to understand their molecular and biochemical mechanisms, as well as new drug productions to counteract diseases. Very deep mechanisms can offer new therapeutic pathways in hematology and oncology, among other fields. However, at least 8-l0 years of further clinical studies are necessary to make a final decision regarding the real clinical importance of basic research. Ideally, an interdisciplinary efforts among basic and clinical researchers are necessary in common research fields. At the same time, genetic research is increasing dramatically (e.g. enzyme mutations). The primary aim of this book is to demonstrate how such research can be used in both fields. This book gathers knowledge from experts in basic and clinical science, biochemistry, pharmacology, molecular pharmacology, genetics, and other fields. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
All rights reserved |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Life Sciences |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/40128">https://directory.doabooks.org/handle/20.500.12854/40128</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://www.intechopen.com/books/adenosine-triphosphate-in-health-and-disease">https://www.intechopen.com/books/adenosine-triphosphate-in-health-and-disease</a> |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="www.oapen.org">www.oapen.org</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
E-Book |